189 related articles for article (PubMed ID: 32983108)
1. Single Nucleotide Polymorphism in
Vargas LB; Dourado RM; Amorim LM; Ho B; Calonga-Solís V; Issler HC; Marin WM; Beltrame MH; Petzl-Erler ML; Hollenbach JA; Augusto DG
Front Immunol; 2020; 11():1881. PubMed ID: 32983108
[TBL] [Abstract][Full Text] [Related]
2. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
3. Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2
Nemat-Gorgani N; Hilton HG; Henn BM; Lin M; Gignoux CR; Myrick JW; Werely CJ; Granka JM; Möller M; Hoal EG; Yawata M; Yawata N; Boelen L; Asquith B; Parham P; Norman PJ
J Immunol; 2018 Apr; 200(8):2640-2655. PubMed ID: 29549179
[TBL] [Abstract][Full Text] [Related]
4. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.
Schönberg K; Sribar M; Enczmann J; Fischer JC; Uhrberg M
Blood; 2011 Jan; 117(1):98-107. PubMed ID: 20935255
[TBL] [Abstract][Full Text] [Related]
5. Loss and Gain of Natural Killer Cell Receptor Function in an African Hunter-Gatherer Population.
Hilton HG; Norman PJ; Nemat-Gorgani N; Goyos A; Hollenbach JA; Henn BM; Gignoux CR; Guethlein LA; Parham P
PLoS Genet; 2015 Aug; 11(8):e1005439. PubMed ID: 26292085
[TBL] [Abstract][Full Text] [Related]
6. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.
Gooneratne SL; Center RJ; Kent SJ; Parsons MS
Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083
[TBL] [Abstract][Full Text] [Related]
7. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
Hilton HG; Vago L; Older Aguilar AM; Moesta AK; Graef T; Abi-Rached L; Norman PJ; Guethlein LA; Fleischhauer K; Parham P
J Immunol; 2012 Aug; 189(3):1418-30. PubMed ID: 22772445
[TBL] [Abstract][Full Text] [Related]
8. Resurrecting KIR2DP1: A Key Intermediate in the Evolution of Human Inhibitory NK Cell Receptors That Recognize HLA-C.
Hilton HG; Blokhuis JH; Guethlein LA; Norman PJ; Parham P
J Immunol; 2017 Mar; 198(5):1961-1973. PubMed ID: 28122963
[No Abstract] [Full Text] [Related]
9. Lack of association of KIR2DL1-R
Loubser S; Da Costa Dias B; Shalekoff S; Gentle NL; Tiemessen CT
Hum Immunol; 2021 Aug; 82(8):600-607. PubMed ID: 33906789
[TBL] [Abstract][Full Text] [Related]
10. Novel Approach to Cell Surface Discrimination Between KIR2DL1 Subtypes and KIR2DS1 Identifies Hierarchies in NK Repertoire, Education, and Tolerance.
Le Luduec JB; Boudreau JE; Freiberg JC; Hsu KC
Front Immunol; 2019; 10():734. PubMed ID: 31024561
[TBL] [Abstract][Full Text] [Related]
11. [The characteristics of frequency distribution of KIR2DL1 alleles polymorphism and recognition HLA-C ligand in the Chinese Han population].
Wang M; He J; Bao XJ; Qiu QC; Li Y; Xu C; Yuan XN; Li LJ
Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1038-43. PubMed ID: 24369161
[TBL] [Abstract][Full Text] [Related]
12. Association of killer cell immunoglobulin-like receptor gene 2DL1 and its HLA-C2 ligand with family history of cancer in oral squamous cell carcinoma.
Dutta A; Saikia N; Phookan J; Baruah MN; Baruah S
Immunogenetics; 2014 Aug; 66(7-8):439-48. PubMed ID: 24818561
[TBL] [Abstract][Full Text] [Related]
13. The combinatorial diversity of KIR and HLA class I allotypes in Peninsular Malaysia.
Tao S; Kichula KM; Harrison GF; Farias TDJ; Palmer WH; Leaton LA; Hajar CGN; Zefarina Z; Edinur HA; Zhu F; Norman PJ
Immunology; 2021 Apr; 162(4):389-404. PubMed ID: 33283280
[TBL] [Abstract][Full Text] [Related]
14. KIR Polymorphism Modulates the Size of the Adaptive NK Cell Pool in Human Cytomegalovirus-Infected Individuals.
Manser AR; Scherenschlich N; Thöns C; Hengel H; Timm J; Uhrberg M
J Immunol; 2019 Oct; 203(8):2301-2309. PubMed ID: 31519864
[TBL] [Abstract][Full Text] [Related]
15. Characterization of KIR
Meazza R; Falco M; Canevali P; Loiacono F; Colomar-Carando N; Muntasell A; Rea A; Mingari MC; Locatelli F; Moretta L; Lopez-Botet M; Pende D
HLA; 2022 Aug; 100(2):119-132. PubMed ID: 35439359
[TBL] [Abstract][Full Text] [Related]
16. Increased frequency and function of KIR2DL1-3⁺ NK cells in primary HIV-1 infection are determined by HLA-C group haplotypes.
Körner C; Granoff ME; Amero MA; Sirignano MN; Vaidya SA; Jost S; Allen TM; Rosenberg ES; Altfeld M
Eur J Immunol; 2014 Oct; 44(10):2938-48. PubMed ID: 25043727
[TBL] [Abstract][Full Text] [Related]
17. KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
Littera R; Piredda G; Argiolas D; Lai S; Congeddu E; Ragatzu P; Melis M; Carta E; Michittu MB; Valentini D; Cappai L; Porcella R; Alba F; Serra M; Loi V; Maddi R; Orrù S; La Nasa G; Caocci G; Cusano R; Arras M; Frongia M; Pani A; Carcassi C
PLoS One; 2017; 12(7):e0180831. PubMed ID: 28686681
[TBL] [Abstract][Full Text] [Related]
18. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
19. KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells.
Sim MJ; Stowell J; Sergeant R; Altmann DM; Long EO; Boyton RJ
Eur J Immunol; 2016 Jan; 46(1):185-91. PubMed ID: 26467237
[TBL] [Abstract][Full Text] [Related]
20. Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells.
Charoudeh HN; Schmied L; Gonzalez A; Terszowski G; Czaja K; Schmitter K; Infanti L; Buser A; Stern M
Immunogenetics; 2012 Oct; 64(10):739-45. PubMed ID: 22772778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
